Document Type
Survey
Title

CSER Phase 2 Patient Reported Utility (PRU) of Clinical Sequencing Survey

Author(s):

Author Name(s)
Clinical Sequence Evidence-Generating Research (CSER Phase 2) Consortium

Year:

Year
2019

The Patient Reported Utility (PRU) of Clinical Sequencing Survey asks participants to rate how useful they find nineteen outcomes of genome sequencing on a scale ranging from 1 (not at all useful) to 7 (extremely useful).

Research Population:

Research Population
Adults
Parents

Share

Related Research Tools

+ Search results